FED LIQUIDITYReserve balances, repo dynamics and front-end funding volatility back at the centre of the macro debate•
US EQUITIESMega-cap index concentration stays extreme as leadership narrows to a handful of AI-linked names•
PRECIOUS METALSGold holds near record highs as central-bank buying and fiscal deficits underpin hard-asset demand•
CHINA POLICYBeijing stimulus and balance-sheet repair remain the swing factor for global trade and EM risk•
FX & RATESDollar cyclicality and rate-cut pricing drive the G10 carry and cross-asset positioning debate•
CREDITPrivate-credit spreads and liability-management activity keep restructuring desks fully occupied•
FED LIQUIDITYReserve balances, repo dynamics and front-end funding volatility back at the centre of the macro debate•
US EQUITIESMega-cap index concentration stays extreme as leadership narrows to a handful of AI-linked names•
PRECIOUS METALSGold holds near record highs as central-bank buying and fiscal deficits underpin hard-asset demand•
CHINA POLICYBeijing stimulus and balance-sheet repair remain the swing factor for global trade and EM risk•
FX & RATESDollar cyclicality and rate-cut pricing drive the G10 carry and cross-asset positioning debate•
CREDITPrivate-credit spreads and liability-management activity keep restructuring desks fully occupied•
US • United StatesAllocators, Wealth & Personal FinanceAnalysisfreemium

The White Coat Investor

Physician Personal Finance

Personal-finance and investing guidance for physicians and high-income professionals.

TypeAnalysis
Asset ClassMulti-Asset
Nichephysician personal finance
Birth Date2011
PriceFree + paid tiers
HeadquartersUnited States
Tierindependent

What it covers

The White Coat Investor is an analysis publication focused on physician personal finance. Its coverage spans Multi-Asset, and it is classified under allocator wealth with a north america orientation, based in United States.

Personal-finance and investing guidance for physicians and high-income professionals.

#Wealth#Personal Finance#Investing

Pricing and access

The White Coat Investor is partly free, with the full archive behind a paid tier.

The publisher does not list public pricing, so budget for a quotation request before committing.

Track record

First published in 2011, which makes it roughly 15 years into its run. Vintage matters in research: surviving one full cycle is a different claim from surviving a bull market.

It carries a Research Authority Score of 80/100, ranked 175 of 444 publications in the index, and is classified as a independent publication.

Who it is for

The White Coat Investor suits readers who want a thesis they can hold for quarters rather than a level to trade today. With a freemium access model and a focus on physician personal finance, it fits readers who already know the sector and want depth rather than an introduction.

If your constraint is time rather than money, the question to ask is whether the publication tells you something the free feed does not: order flow, a primary-source ledger, a model, or a mechanism nobody else has priced.

How it is scored

Every publication in this index is scored 0 to 100 on the same five pillars: primary-source rigour (35%), differentiated niche edge (25%), track record and vintage (15%), institutional adoption (15%), and transparency and independence (10%). The White Coat Investor scores 80.

Paid placement on this site affects visual prominence only. It never changes a publication's description, classification or score.

Frequently asked

How much does The White Coat Investor cost?
Free + paid tiers.
What does The White Coat Investor cover?
The White Coat Investor covers physician personal finance, across Multi-Asset. It is published as a analysis publication from United States.
How is The White Coat Investor ranked on newsletters.markets?
It scores 80/100, ranked 175 of 444 publications in the index. Scoring weights primary-source rigour, niche depth, track record, institutional adoption and transparency. Paid placement never changes the score.
What are the best alternatives to The White Coat Investor?
The top alternatives to The White Coat Investor include competing publications and research desks covering physician personal finance in the allocator wealth sector. View the alternatives tab for side-by-side pricing and scores.
Who is The White Coat Investor best for?
The White Coat Investor is best suited for institutional investors, analysts, and active traders seeking analysis coverage in physician personal finance.
Is there a free tier of The White Coat Investor?
Yes. The White Coat Investor operates a freemium model, so you can read the free output before paying for the full archive.

Related Research Desks & Publications